CHEMICAL RENAL DENERVATION WITH ALCOHOL – LONG TERM RESULTS FROM THE PEREGRINE POST-MARKET STUDY
Persu A, Renkin J, Hochul M, Wojakowski W, Böhm M, Mahfoud F, Schmieder R, van der Giet M, de Bucourt M, Zirlik A, Neuzil P, Haratani N, Parise H, Fischell T, Bertog S, Sievert K, Sievert H. CHEMICAL RENAL DENERVATION WITH ALCOHOL – LONG TERM RESULTS FROM THE PEREGRINE POST-MARKET STUDY. Journal Of Hypertension 2018, 36: e123. DOI: 10.1097/01.hjh.0000539319.18701.45.Peer-Reviewed Original ResearchSystolic office blood pressureChemical renal denervationResistant hypertensionPost-market studyRenal denervationVascular access site complicationsWhite-coat resistant hypertensionMajor efficacy endpointsMulticenter European trialSignificant BP reductionOffice blood pressureRenal artery dissectionTransient ischemic attackAccess site complicationsAnti-hypertensive medicationsMean procedure timeMajor safety endpointsML of alcoholAnatomical eligibilityAntihypertensive medicationsBP reductionEligible patientsIschemic attackOpen labelRenal events